🇺🇸 FDA
Pipeline program

60 µg dose hepatitis B vaccine

2012ZX10002001003004003

Approved mab completed

Quick answer

60 µg dose hepatitis B vaccine for Hepatitis B Vaccine is a Approved program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hepatitis B Vaccine
Phase
Approved
Modality
mab
Status
completed

Clinical trials